Duality Advisers, LP Rocket Pharmaceuticals, Inc. Transaction History

Duality Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$13.16 - $23.68 $644,089 - $1.16 Million	-48,943 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$21.52 - $36.02 $176,033 - $294,643	8,180 Added 20.07%	48,943 $1.07 Million
Q3 2021 Nov 08, 2021	BUY	$27.42 - $48.97 $1.12 Million - $2 Million	40,763 New	40,763 $1.22 Million
Q2 2021 Aug 09, 2021	SELL	$39.41 - $47.25 $929,642 - $1.11 Million	-23,589 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $1.02 Million - $1.55 Million	23,589 New	23,589 $1.05 Million
Q4 2020 Feb 09, 2021	SELL	$23.3 - $59.57 $238,592 - $609,996	-10,240 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$20.5 - $28.59 $209,920 - $292,761	10,240 New	10,240 $234,000

210

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $951M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.